Clinical Trials Update: Feb. 26, 2007
Smoking Cessation Bipolar Disorders Bladder Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This research study will utilize the Internet to help pregnant women stop smoking. Women 18-45 who are smokers and pregnant may be eligible. People who qualify will be compensated, and participation will be confidential.
The research site is in Lexington, Ky.
This study will evaluate the safety and effectiveness of an investigational drug in treating bipolar disorder with a depressive episode. Volunteers 18-65 who have any of these symptoms may be included: difficulty concentrating, remembering, or making decisions, loss of energy, fatigue, changes in appetite and/or weight, or thoughts of death or suicide.
The research site is in Portland, Ore.
This study will test an investigational drug, vinflunine (BMS-710485), in combination with gemcitabine in people with transitional cell carcinoma who cannot be treated with cisplatin. Candidates at least 18 who have a clinical diagnosis of transitional cell carcinoma of the urothelium that is locally advanced or metastatic may be eligible.
The research sites are located across the United States.
Copyright 2007 Thomson CenterWatch. All rights reserved.